retatrutide ly3437943 glp-1 gip glucagon receptor agonist just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Eli Lilly: GLP-1R/GCGR/GIPR Triagonist Reduces
Description
Syringe selection: Use an insulin syringe with a 29 to 31 gauge needle
doi: 10.3390/ijms160920195 100 TokiSNewcombDCPrintzRLCahillKNBoydKLNiswenderKDet al
Based on a preliminary evaluation of weight loss trajectories at multiple dose levels, the company believes that continued treatment beyond 28 days may provide further reductions in body weight
[DOI] [PubMed] [Google Scholar] [67].Wang Y, Lomakin A, Kanai S, Alex R, Belli S, Donzelli M, Benedek GB, The molecular basis for the prolonged blood circulation of lipidated incretin peptides: Peptide oligomerization or binding to serum albumin?, Journal of controlled release : official journal of the Controlled Release Society, 241 (2016) 2533
Eyeglasses do not help because NAION is related to nerve damage that is usually considered permanent
